Companies / Financials
SPGI
S&P Global
Financial Exchanges & Data
Financial Exchanges & DataAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health83
Growth57
Profitability100
Cash generationn/a
Balance sheetn/a
Dilution control92
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)6.8%Revenue growth (FY)7.9%Revenue CAGR (3y)11.1%Gross margin70.2%Operating margin42.2%Net margin29.2%Free cash flow margin35.6%R&D / revenue—Stock comp / revenue1.5%Net debt / operating cash flow2.13xCurrent ratio0.82Diluted share count change-2.2%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $8.3B | $11.2B | $12.5B | $14.2B | $15.3B |
| Gross profit | $6.1B | $7.4B | $8.4B | $9.8B | $10.8B |
| Operating income | $4.2B | $4.9B | $4.0B | $5.6B | $6.5B |
| Net income | $3.0B | $3.2B | $2.6B | $3.9B | $4.5B |
| Operating cash flow | $3.6B | $2.6B | $3.7B | $5.7B | $5.7B |
| Capital expenditure | $35M | $89M | $143M | $124M | $195M |
| Free cash flow | $3.6B | $2.5B | $3.6B | $5.6B | $5.5B |
| Stock-based comp | $122M | $214M | $171M | $247M | $236M |
| Buybacks | $0 | $12.0B | $3.3B | $3.3B | $5.0B |
| Dividends | $743M | $1.0B | $1.1B | $1.1B | $1.2B |
| Cash | $6.5B | $1.3B | $1.3B | $1.7B | $1.7B |
| Total debt | $4.1B | $11.2B | $11.5B | $11.4B | $13.8B |
| Equity | $2.0B | $36.4B | $34.2B | $33.2B | $31.1B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.